Subtypes of humanized antibody against interleuken-6 receptor
As a subtype of humanized PM-1 antibody against interleukin-6 receptor (IL-6R), there is provided antibody sub-type (1) whose one heavy chain C terminus consists of Pro-NH 2 (447). As another subtype of humanized PM-1 antibody against interleukin-6 receptor (IL-6R), there is provided antibody subtype (2) whose both heavy chain C termini consist of Pro-NH 2 (447). Furthermore, there are provided pharmaceutical compositions comprising these.
1. An antibody subtype (1) which is a subtype of the humanized PM-1 antibody against interleukin-6 receptor (IL-6R) comprising a heavy chain that has amino acids 1-448 of the amino acid sequence set forth in SEQ ID NO: 1, a heavy chain that has amino acids 1-447 of the amino acid sequence set forth in SEQ ID NO: 1 and a C-terminal that is Pro-NH 2 , and a light chain that has the amino acid sequence set forth in SEQ ID NO: 2.
2. The antibody subtype according to claim 1 wherein glutamine (Gln) at the heavy chain N-terminal is replaced with pyroglutamic acid (pGlu).
3. A pharmaceutical composition comprising the antibody subtype according to claim 2 .
4. A pharmaceutical composition comprising the antibody subtype (1) of claim 1 .
5. An antibody subtype (2) which is a subtype of the humanized PM-1 antibody against interleukin-6 receptor (IL-6R) in which both heavy chains have amino acids 1-447 of the amino acid sequence set forth in SEQ ID NO: 1 and a C-terminal that is Pro-NH 2 , and comprising a light chain that has the amino acid sequence set forth in SEQ ID NO: 2.
6. A pharmaceutical composition comprising the antibody subtype (2) of claim 4 .
7. The antibody subtype according to claim 4 wherein glutamine (Gln) at the heavy chain N-terminal is replaced with pyroglutamic acid (pGlu).
8. A pharmaceutical composition comprising the antibody subtype according to claim 7 .
9. A pharmaceutical composition comprising the antibody subtype according to claim 2 and the antibody subtype according to claim 7 .
10. A pharmaceutical composition comprising:
an antibody subtype (1) which is a subtype of the humanized PM-1 antibody against interleukin-6 receptor (IL-6R) comprising a heavy chain that has amino acids 1-448 of the amino acid sequence set forth in SEQ ID NO: 1, a heavy chain that has amino acids 1-447 of the amino acid sequence set forth in SEQ ID NO: 1 and a C-terminal that is Pro-NH 2 , and a light chain that has the amino acid sequence set forth in SEQ ID NO: 2; and
an antibody subtype (2) which is a subtype of the humanized PM-1 antibody against interleukin-6 receptor (IL-6R) in which both heavy chains have amino acids 1-447 of an amino acid sequence set forth in SEQ ID NO: 1 and a C-terminal that is Pro-NH 2 , and comprising a light chain that has the amino acid sequence set forth in SEQ ID NO: 2.